Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
mental retardation, non-syndromic, autosomal recessive, 4 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||||
|
Potocki-Lupski syndrome | 0.780 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
TRAF family member associated NFKB activator | 0.678 | 0.500 | 0.84 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
steroid receptor RNA activator 1 | 0.568 | 0.615 | 5.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 0.617 | 0.269 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
SH2 domain containing 3A | 0.760 | 0.423 | 3.6E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
EGF like repeats and discoidin domains 3 | 0.564 | 0.769 | 1.5E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fem-1 homolog B | 0.821 | 0.385 | 0.35 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
B cell receptor associated protein 31 | 0.579 | 0.808 | 0.43 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
uncharacterized LOC101928437 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
oligodendrocyte transcription factor 2 | 0.560 | 0.577 | 9.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cyclin dependent kinase 2 associated protein 2 | 0.544 | 0.808 | 0.79 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
sigma non-opioid intracellular receptor 1 | 0.544 | 0.808 | 0.17 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 | 0.576 | 0.654 | 0.76 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
semaphorin 4B | 0.743 | 0.269 | 5.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 237 | 0.931 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
uroplakin 3B | 0.584 | 0.808 | 2.3E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
mab-21 like 2 | 0.743 | 0.308 | 0.44 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
trafficking protein particle complex 2B | 0.861 | 0.192 | 2.9E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
SH2B adaptor protein 2 | 0.623 | 0.731 | 1.5E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
centromere protein F | 0.601 | 0.654 | 1.9E-36 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
cAMP regulated phosphoprotein 21 | 0.663 | 0.654 | 1.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |